313 related articles for article (PubMed ID: 3035513)
1. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
Bhargava HN; Das S; Bansinath M
Peptides; 1987; 8(2):231-5. PubMed ID: 3035513
[TBL] [Abstract][Full Text] [Related]
2. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Bhargava HN; Gulati A
Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
[TBL] [Abstract][Full Text] [Related]
3. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Bhargava HN; Rahmani NH
Pharmacology; 1993; 46(2):75-81. PubMed ID: 8382821
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
Bhargava HN; Gulati A
Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
[TBL] [Abstract][Full Text] [Related]
5. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
Bhargava HN; Das S; Bansinath M; Prasad R
Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
[TBL] [Abstract][Full Text] [Related]
6. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
Sharif NA
Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
Bhargava HN; Gulati A; Rahmani NH
Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of central binding sites for [3H] DAMGO in spontaneously hypertensive rats.
Gulati A; Bhargava HN
Life Sci; 1990; 47(2):159-66. PubMed ID: 2167417
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Das S; Bhargava HN
Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
[TBL] [Abstract][Full Text] [Related]
10. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats.
Bhargava HN; Ramarao P; Gulati A; Matwyshyn GA; Prasad R
Arch Int Pharmacodyn Ther; 1989; 297():247-59. PubMed ID: 2499290
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
Rahmani NH; Gulati A; Bhargava HN
Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
[TBL] [Abstract][Full Text] [Related]
12. Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Rahmani NH; Gulati A; Bhargava HN
Life Sci; 1991; 48(26):2499-504. PubMed ID: 2046475
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
Sullivan NJ; Lautens LL; Tashjian AH
Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
[TBL] [Abstract][Full Text] [Related]
14. Cocaine-induced changes in 3H-naloxone binding in brain membranes isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Ishizuka Y; Rockhold RW; Hoskins B; Ho IK
Life Sci; 1988; 43(26):2275-82. PubMed ID: 2850430
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleotide regulation of receptor binding of thyrotropin-releasing hormone (TRH) in rat brain regions, retina and pituitary.
Sharif NA; Burt DR
Neurosci Lett; 1987 Oct; 81(3):339-44. PubMed ID: 2829061
[TBL] [Abstract][Full Text] [Related]
16. Brain corticotropin releasing factor in the spontaneously hypertensive rat.
Hattori T; Hashimoto K; Ota Z
Hypertension; 1986 Nov; 8(11):1027-31. PubMed ID: 3490439
[TBL] [Abstract][Full Text] [Related]
17. Opioid peptides in pituitary gland, brain regions and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
Bhargava HN; Matwyshyn GA; Hanissian S; Tejwani GA
Brain Res; 1988 Feb; 440(2):333-40. PubMed ID: 2896047
[TBL] [Abstract][Full Text] [Related]
18. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
Gulati A; Arora RC; Crayton J
Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II.
Gattu M; Terry AV; Pauly JR; Buccafusco JJ
Brain Res; 1997 Oct; 771(1):104-14. PubMed ID: 9383013
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-releasing hormone hyperactivity in the preoptic area of spontaneously hypertensive rats.
Garcia SI; Dabsys SM; Martinez VN; Delorenzi A; Santajuliana D; Nahmod VE; Finkielman S; Pirola CJ
Hypertension; 1995 Dec; 26(6 Pt 2):1105-10. PubMed ID: 7498977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
